Refractive Surgery
Hovanesian interviews Mazzo on ophthalmology’s future in coronavirus pandemic era
In this video, OSN Cataract Surgery Section Editor John A. Hovanesian, MD, FACS, interviews Jim Mazzo, president of the ophthalmic devices strategic business unit for Zeiss, about what changes will take place in the ophthalmic industry and physician practices with the coronavirus pandemic. What follows is a lightly edited transcription of the interview.
Ophthalmic revenues, surgeries may recover once patient safety can be assured
VIDEO: Surgeon shares latest data on pinhole technologies
VIDEO: Surgically induced astigmatism in toric IOL calculations
VIDEO: Surgeon announces innovation in excimer laser surgery
VIDEO: Surgeon speaks about intrastromal lenticule rotation
Large study shows efficacy of combining cross-linking with SMILE in corneas at risk for ectasia
Adding a fellow to practice adds efficiency and invigorates the surgeon
Expect challenges, demands from former refractive surgery patients with cataracts
Bringing ‘scatter’ back: enhanced conversions and outcomes
With the new year in full blossom and it being 2020, patients will now be expecting 20/20 vision at the minimum. As premium surgeons, is 20/20 even adequate enough for our patients, and does a quantity of vision really tell the story of patient satisfaction? In reality, quantifying the quality of our patient visual outcomes and eventually enhancing our patient conversions to premium technology in a year of significant financial reductions become paramount. Bringing “scatter” back may be what the doctor needs to start the 2020 year.